title: Amphibian (Xenopus laevis) tadpoles and adult frogs mount distinct interferon responses to the Frog Virus 3 ranavirus.
abstract: Infections of amphibians by Frog Virus 3 (FV3) and other ranavirus genus members are significantly contributing to the amphibian declines, yet much remains unknown regarding amphibian antiviral immunity. Notably, amphibians represent an important step in the evolution of antiviral interferon (IFN) cytokines as they are amongst the first vertebrates to possess both type I and type III IFNs. Accordingly, we examined the roles of type I and III IFNs in the skin of FV3-challenged amphibian Xenopus laevis) tadpoles and adult frogs. Interestingly, FV3-infected tadpoles mounted type III IFN responses, whereas adult frogs relied on type I IFN immunity. Subcutaneous administration of type I or type III IFNs offered short-term protection of tadpoles against FV3 and these type I and type III IFNs induced the expression of distinct antiviral genes in the tadpole skin. Moreover, subcutaneous injection of tadpoles with type III IFN significantly extended their survival and reduced FV3 dissemination.
authors.affiliation: Department of Biological Sciences, George Washington University, Washington, DC, USA.
authors.forename: Emily S
authors.initials: ES
authors.lastname: Wendel
authors.affiliation: Department of Biological Sciences, George Washington University, Washington, DC, USA.
authors.forename: Amulya
authors.initials: A
authors.lastname: Yaparla
authors.affiliation: Department of Biological Sciences, George Washington University, Washington, DC, USA.
authors.forename: Daphne V
authors.initials: DV
authors.lastname: Koubourli
authors.affiliation: Department of Biological Sciences, George Washington University, Washington, DC, USA. Electronic address: leon_grayfer@gwu.edu.
authors.forename: Leon
authors.initials: L
authors.lastname: Grayfer
mesh_terms: D000818:Animals; D001384:Azetidines / Q000494:pharmacology; D016207:Cytokines / Q000494:pharmacology; D004266:DNA Virus Infections / Q000276:immunology* / Q000821:virology; D007370:Interferon Type I / Q000276:immunology* / Q000494:pharmacology; D007372:Interferons / Q000276:immunology* / Q000494:pharmacology; D007814:Larva / Q000276:immunology* / Q000821:virology; D011687:Purines; D011720:Pyrazoles; D017995:Ranavirus / Q000276:immunology*; D012867:Skin / Q000276:immunology; D013449:Sulfonamides / Q000494:pharmacology; D019562:Viral Load / Q000276:immunology; D029867:Xenopus Proteins / Q000276:immunology* / Q000494:pharmacology; D014982:Xenopus laevis / Q000276:immunology* / Q000821:virology*
chemical_list: D001384:Azetidines; D016207:Cytokines; D007370:Interferon Type I; D011687:Purines; D011720:Pyrazoles; D013449:Sulfonamides; D029867:Xenopus Proteins; D007372:Interferons; C000596027:baricitinib
keywords: Amphibian; Antiviral; FV3; Frog Virus 3; IFNα; IFNλ; Interferon; Ranavirus